Long‐term prognostic implications of nonoptimal primary angioplasty for acute myocardial infarction

Abstract

A nonoptimal primary PCI result represents a strong predictor of early mortality. However, in patients surviving the early phase, the incidence of clinical events at long-term follow-up seems to be similar to successfully reperfused AMI patients.

Post-procedural TIMI flow grade 2 is not associated with improved prognosis in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary revascularization (PL-ACS registry)

“…Initial total artery occlusion may reflect higher clot burden, the lack of spontaneous clot lysis, and higher amounts of thrombi and plaque material, leading to distal embolization. These findings are in agreement with previous studies on patients with STEMI undergoing PCI [12][13][14]. More advanced coronary lesions in combination with poorer initial flow in the IRA in TIMI 0-1 and 2 groups were responsible for the higher rate of revascularization failure.…”

Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction

“…Mortality after 30 days was comparable between the 2 groups. Similar results were recently reported in a large cohort of patients (47).…”

Effect of Oral Atorvastatin on CD4+CD25+ Regulatory T Cells, FoxP3 Expression, and Prognosis in Patients With ST-Segment Elevated Myocardial Infarction Before Primary Percutaneous Coronary Intervention

“…The PCI results were defined as final forward flow TIMI Grade 3 and residual stenosis less than 20% in the ICA at the end of the procedure. 16,17 Flow Cytometry…”